BioSpace News Archive

Business

Biotechs Have Busy Week of Financing Rounds

Yesterday marked the close of three new financing rounds in the biotech space. Although none of today’s are that large, there is still plenty of money on the move. Here’s a look.

March 16, 2021
·
3 min read
·
Mark Terry
Policy

The Race to a COVID-19 Vaccine Ignites a Cold War-Type Era with Russia

The COVID-19 pandemic is not only an international health crisis, but a burgeoning geopolitical exercise for Russia to win the hearts and minds of a large portion of the world while undermining the West.

March 16, 2021
·
4 min read
·
Gail Dutton
Business

ExeVir Snags $50 Million to Take Llama Antibody into First In-Human Trials

German shepherds take down bad guys, dalmatians pull people from fires, beagles sniff out bombs and now llamas fight COVID-19.

March 16, 2021
·
2 min read
·
Kate Goodwin
FDA

FDA Approves Melinta Antibiotic for Serious Skin Infections

The drug is a lipoglycopeptide antibiotic. It is given in a single, one-hour infusion.

March 16, 2021
·
3 min read
·
Mark Terry
BioMidwest

AbbVie Could Sell Off $5 Billion Portfolio of Women’s Drugs

One year after AbbVie’s $63 billion purchase of Allergan, the company is reportedly lining up the sale of a portfolio of women’s drugs and health care products valued at $5 billion.

March 16, 2021
·
2 min read
·
Alex Keown
Business

Be Bio Brings in New Talent for Top Roles

Five months after Be Biopharma launched with $52 million in Series A financing, the company tapped bluebird bio veteran Joanne Smith-Farrell as its new chief executive officer.

March 16, 2021
·
2 min read
·
Alex Keown
Drug Development

2021 Biopharma Update on the Novel Coronavirus: March 16

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 16, 2021.

March 16, 2021
·
4 min read
·
BioSpace Editorial Staff
Money on the Move: March 10-16

Life sciences money is seemingly growing on trees this year. Here’s who picked a good harvest this week.

March 16, 2021
·
5 min read
·
Kate Goodwin
CRISPR Screening IDs Host Factors Essential for Coronavirus Entry into Cells

Identifying the common host factors that are essential for coronavirus replication is an important element in developing broad-spectrum, antiviral therapeutics.

March 16, 2021
·
5 min read
·
Gail Dutton
Drug Development

Janssen’s Psoriatic Arthritis Drug, TREMFYA, Proves Long-Term Efficacy in Two-Year Trial

Long-term data from Janssen’s Phase III DISCOVER-2a trial show that TREMFYA® (guselkumab), a selective IL-23 inhibitor, lead to skin clearance and joint symptom relief for up to two years in patients with active psoriatic arthritis.

March 16, 2021
·
2 min read
·
Brandon May